Is Zomedica [ZOM] Stock A Buy or Sell Now? Think about this...

Is Zomedica [ZOM] Stock A Buy or Sell Now? Think about this...

My Links for More $$$ • How I invest in Real Estate with little money: https://fundrise.sjv.io/MXXDKM • Broke Man Finance Discord:   / discord   • “Stock Whispers” for Great Tips and Breaking News: https://t.me/SWReferralBot?start=invf... • Get $10 Free Bitcoin: https://www.coinbase.com/join/wilson_45f • My Savings Account - Yotta Savings Account! Use code Adam94 for free tickets! • Subscribe to my Patreon   / adambrokemanfinance   My “Best-Sellers” • “Tactical Reload” Book & Audio Book https://amzn.to/39ZIhTs • “Typo: What the Media Gets Right About Policing” Book Only https://amzn.to/39f2vcQ Favorite Finance Books: • “Invested” https://amzn.to/3c7QCXZ • “I Will Teach You To Be Rich” https://amzn.to/39dXZes • “Think and Grow Rich” https://amzn.to/3c4CTkF • “Rich Dad Poor Dad” https://amzn.to/3sTex39 • “Principles: Life and Work ” https://amzn.to/3qHXwXM Disclaimer: None of the information in this video should be considered as advice. This video was made for entertainment purposes only. who Zomedica signed a distribution deal with because that announcement made me even more bullish, The name is Miller, not the beer you bunch of drunkys, the veterinary supply distributor. Miller is highly respected in their field and have been around for more than 100 years. They’re growing aggressively. The family sold ownership of Miller Veterinary Supply to some partners with whom they have been dealing with since 2017. In fact, since then they’ve opened up offices in three new states NJ, GA, & FL but remain headquartered in TX. Rumor has it they’re trying to expand to the northeast and more west and that possibility doesn’t seem far-fetched under the company restructuring. Under the terms of the distribution agreement, Miller will be representing Zomedica in states ranging from Texas to Maine, concentrated in the eastern and mid-eastern portion of the United States. Now this is what is what Miller had to say about Zomedica, Clay Cass, Executive Vice President and Chief Operating Officer of Miller, commented that: “It isn’t often that an industry-changing product like TRUFORMA™ comes along. We are honored and excited to have been chosen to help bring this technology to market. We look forward to working together with Zomedica to introduce TRUFORMA to our many valued customers and the pets in their care.” Now take a moment and think about that statement, industry changing product. This is a company that’s been around for over 100 years. I’m talking survived through the great depression. And they are calling Truforma industry changing. As far as leadership, one person on Zomedica’s board gives me even more confidence. Now everyone on their board I’m sure is great in their field of expertise. But I was excited to see Dr. Johnny Powers. Dr. Powers brings over 30 years of experience but Notably, he held executive roles at animal health industry leader IDEXX Laboratories, (IDEXX), where, prior to his retirement, he served as executive vice president responsible for business performance, product innovation and commercial effectiveness across multiple point-of-care and reference laboratory businesses. If you don’t know, IDEXX is a big dog in this space who boasts a share price of $520 currently. Dr. Powers helped get IDEXX there and now he’s helping Zomedica grow. Plus, ZOM has cash and cash equivalents of $90 million. The company expects for that to fund operations through 2023 — and expects to be cash flow positive by then. We have a young company, with an industry changing product and more in the pipe, a new distributor that is also growing aggressively, in a massively growing pet industry, with leadership that has helped grow similar companies into power houses. That’s a recipe I don’t mind spending less than $2 a share on, because of over time, that has success written all over it. Fair warning, this is all speculative until we see some numbers and action. Zomedica right now is 100% a spec play and technically, I would say they’re over bought and expectations are bought into the share price. Make sure your due diligence, however, I believe, like many of you that they are sitting on a mega product for the vet world and they will see an enormous amount of revenue. Truforma alone has like 70 different associated patents. Meaning, it’s almost March, and it closed today at $1.85. March 30 is just around the corner, and we could be looking at a steal right now. I fully expect my investment to 10x my money and more at some point. It will take years, but Zomedica could reach IDEXX levels. But IDEXX has a 30 year head start. #zom #pennystocks #zomedica